ZTS.NYSEZoetis INC

Form 4: Zoetis Inc. Director Frank A. Damelio Reports Stock Unit Transactions

Sentiment:

SEC Form 4 Filing


Director Frank A. Damelio reports the acquisition of deferred stock units and vesting of restricted stock units in Zoetis Inc.

Summary

  • Frank A. Damelio, a director of Zoetis Inc., reported transactions involving restricted stock units (RSUs) and deferred stock units (DSUs) on February 8, 2025.
  • The transactions include the vesting of 1,225.4023 RSUs, which were then converted into deferred stock units (DSUs) under the Zoetis Inc. Amended and Restated Non-Employee Director Deferred Compensation Plan.
  • Additionally, 1,225.4023 DSUs were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.
  • Following these transactions, Damelio holds 9,857.404 DSUs under the Amended and Restated Non-Employee Director Deferred Compensation Plan and 9,996.7233 DSUs under the 2013 Equity and Incentive Plan.

Sentiment

Score: 7

Explanation: The document reflects standard executive compensation practices, indicating a stable and well-managed company. The sentiment is neutral to positive.

Positives

  • The vesting of RSUs and subsequent conversion to DSUs indicates continued alignment of the director's interests with the long-term performance of Zoetis Inc.
  • The grant of DSUs under the equity incentive plan further incentivizes the director.

Future Outlook

The deferred stock units will be settled in shares of Zoetis Inc. common stock upon the reporting person's separation from service as a director.

Industry Context

This filing is a routine disclosure of stock-based compensation for a director, which is a common practice in publicly traded companies to align management's interests with shareholders.

Comparison to Industry Standards

  • Stock-based compensation is a standard practice among publicly traded companies, including Zoetis's competitors in the animal health industry such as Elanco and Merck Animal Health.
  • The specific terms of the equity and incentive plans, such as vesting schedules and deferral options, are generally comparable to those offered by peer companies to attract and retain qualified directors.

Stakeholder Impact

  • The transactions have a minor impact on shareholders as they represent a small portion of the company's outstanding shares.
  • The equity compensation plan incentivizes the director to act in the best interests of the company and its shareholders.

Key Dates

DateDescription
02/08/2022Original grant date of the restricted stock units that vested on February 8, 2025.
02/08/2025Date of transaction: vesting of restricted stock units and acquisition of deferred stock units.
02/11/2025Date of filing of the Form 4.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.